TEVA PHARMACEUTICAL INDUSTRIES LTD·4

Sep 5, 4:08 PM ET

Halfon Jean Michel 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Sep 5, 2018

Insider Transaction Report

Form 4
Period: 2018-09-05
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2018-09-03+2,1622,162 total
  • Exercise/Conversion

    Restricted Share Units

    2018-09-032,1620 total
    Ordinary Shares (2,162 underlying)
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on October 7, 2015 and vested on September 3, 2018.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION